Re: Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study
Thank you for your interest in our paper and your valuable remarks. We studied the effect on the newborn of intrauterine exposure to neuraminidase inhibitors and could not find any negative consequences. In the present study we did not have information on the vaccination status of the pregnant women and hence we do not draw any conclusions on the benefit of vaccination versus the benefit of post exposure prophylaxis as the preferable strategy to protect women and infants.
Best Regards, on behalf of the authors
Competing interests: No competing interests